April 29, 2020 / 3:28 AM / a month ago

BRIEF-Strides Pharma Science Develops, Commences Export Of Favipiravir Antiviral Tablets

April 29 (Reuters) - Strides Pharma Science Ltd:

* STRIDES DEVELOPS AND COMMENCES EXPORT OF FAVIPIRAVIR ANTIVIRAL TABLETS

* FAVIPIRAVIR TABLETS HAVE DEMONSTRATED POSITIVE OUTCOMES IN COVID-19 TREATMENT GLOBALLY

* STRIDES TO APPLY TO INDIAN DRUG AUTHORITIES TO START NECESSARY STUDIES, MAKE DRUG AVAILABLE TO INDIAN PATIENTS EXPEDITIOUSLY Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below